Mucormycosis is an aggressive and potentially fatal fungal infection caused by fungi of the order Mucorales. There has been an increase in the number of cases of rhino-orbital mucormycosis in people with COVID-19, particularly in India. Rhino-orbital-cerebral mucormycosis is the most common manifestation of mucormycosis associated with COVID-19. We report the first case of rhino-orbital mucormycosis in a diabetic patient with SARS-CoV-2 infection in Malaysia. The diagnosis of mucormycosis was confirmed by histopathological examination, but the fungal culture and PCR results were negative. He was treated with antifungal therapy and had extensive debridement. Treatment of mucormycosis requires a multidisciplinary approach that includes addressing underlying risk factors, effective antifungal therapy, and surgical debridement.
CITATION STYLE
Chang, C. Y., Gan, Y. L., Zamri, F. I., & P. Radhakrishnan, A. (2022). Rhino-orbital Mucormycosis in a COVID-19 Patient: The First Case in Malaysia. Proceedings of Singapore Healthcare, 31. https://doi.org/10.1177/20101058221074112
Mendeley helps you to discover research relevant for your work.